Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin-associated protein 3-1 (KRTAP3-1) is a member of the keratin-associated protein (KAP) family, specifically classified within the high sulfur KAP subgroup. These proteins form an interfilamentous matrix with hair keratin intermediate filaments in the hair cortex, contributing substantially to the structural rigidity and resilience of hair fibers by establishing extensive disulfide bonds with keratin proteins. Each KAP family member, including KRTAP3-1, possesses distinctive amino- and carboxyl-terminal sequences, and the human KRTAP3-1 gene maps to a cluster on chromosome 17q12-q21. Although KRTAP3-1 is a structurally vital gene for hair biology, it is not recognized as a therapeutic target, receptor, enzyme, transporter, or transcription factor, and there are no currently known drugs or therapeutic interventions directly interacting with it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin-associated protein 3-1 (KRTAP3-1).